[1] | Yitong BAI, Lianjie LIN, Dongmei PEI. Value of red blood cell distribution width-to-platelet ratio in evaluating metabolic-associated fatty liver disease and liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(4): 805-809. doi: 10.3969/j.issn.1001-5256.2022.04.013 |
[2] | Dezhao LI, Jian LI, Xiaolin GUO. Value of albumin-bilirubin score in predicting the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2021, 37(5): 1085-1090. doi: 10.3969/j.issn.1001-5256.2021.05.022 |
[3] | Minrui YU, Jie YANG, Jinyong WANG, Bo ZHOU, Bin JIANG, Baocheng DENG. Value of spleen stiffness measured by two-dimensional shear wave elastography combined with platelet count/spleen diameter ratio in evaluating moderate-to-severe gastroesophageal varices in patients with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(7): 1572-1577. doi: 10.3969/j.issn.1001-5256.2021.07.019 |
[4] | Shuang FENG, Huifen FENG, Jing XU, Gongchao YU, Shan ZHENG. Value of FibroScan and platelet count-to-spleen thickness ratio in predicting the degree of esophageal and gastric varices in liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(12): 2819-2823. doi: 10.3969/j.issn.1001-5256.2021.12.018 |
[5] | Qun ZHANG, Shuaishuai NIU, Xianbo WANG. Role of probiotics in primary prevention of esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2021, 37(2): 331-335. doi: 10.3969/j.issn.1001-5256.2021.02.017 |
[6] | Zhen LI, Chunqing ZHANG. Esophageal and gastric variceal bleeding in liver cirrhosis: Embolization or shunt[J]. Journal of Clinical Hepatology, 2021, 37(12): 2764-2766. doi: 10.3969/j.issn.1001-5256.2021.12.004 |
[7] | Ma JiaLi, He LingLing, Li Ping, Jiang Yu, Hu JuLong, Zhou YuLing, Liang XiuXia, Wei HongShan. Influence of alcohol consumption on liver function and rebleeding in alcoholic cirrhotic patients with esophageal and gastric varices[J]. Journal of Clinical Hepatology, 2019, 35(11): 2478-2482. doi: 10.3969/j.issn.1001-5256.2019.11.018 |
[8] | Li XiaoLu, Li Lei. Application of terlipressin in the treatment of esophagogastric variceal bleeding in liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2308-2311. doi: 10.3969/j.issn.1001-5256.2019.10.038 |
[9] | Ai ZhengLin, Hong Shan, Hu JuLong, Li Ping, Zhou YuLing, Liang XiuXia. Establishment and evaluation of a predictive model for rebleeding after endoscopic treatment of esophageal and gastric varices[J]. Journal of Clinical Hepatology, 2019, 35(9): 1954-1957. doi: 10.3969/j.issn.1001-5256.2019.09.014 |
[10] | Duan ZhiHui, Zhou ShengYun, Li ZengKui, Zhai DongCai, Zhou KeRou, Sun XiaoFang, Wang YanHong, Wu YiJuan, Li SuRong, Wang JiTao. Value of platelet count and gallbladder wall thickness in predicting esophageal varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2716-2720. doi: 10.3969/j.issn.1001-5256.2019.12.015 |
[11] | Peng YiQiu, Wang YongJun. Clinical effect of endoscopic application of tissue adhesive and ligation in treatment of esophagogastric variceal bleeding in children: An analysis of 16 cases[J]. Journal of Clinical Hepatology, 2018, 34(9): 1921-1924. doi: 10.3969/j.issn.1001-5256.2018.09.019 |
[12] | He Yang, Su YaRong, Han ZiYan. Current status of research on primary and secondary risk factors for esophagogastric variceal rebleeding in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(7): 1555-1559. doi: 10.3969/j.issn.1001-5256.2018.07.041 |
[13] | Lin FanYu, Huang Hua, Lu MingLiang. Research advances in prognostic factors for patients with esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2018, 34(11): 2428-2432. doi: 10.3969/j.issn.1001-5256.2018.11.036 |
[14] | Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Gastroenterology, Chinese Medical Association, Chinese Society of Endoscopy,Chinese Medical Association. Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(2): 203-219. doi: 10.3969/j.issn.1001-5256.2016.02.002 |
[15] | Ding HuiGuo, Xu XiaoYuan, Ling HuEnQiang, Jia JiDong. Interpretation of guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(2): 220-222. doi: 10.3969/j.issn.1001-5256.2016.02.003 |
[16] | Liu XiuHong, Zhao YiMing, Li Ning, Jin BoXun, Yan HuiPing, Zhao YuanShun, Li Ang, Han Zhen, Zhang AiYing. Diagnostic values of plasma Golgi protein-73 and platelet count for different stages of HBV-related liver diseases[J]. Journal of Clinical Hepatology, 2015, 31(9): 1469-1472. doi: 10.3969/j.issn.1001-5256.2015.09.025 |
[17] | Yang Yan, Fan YanHua, Fang Long, Gao Chun, Du ShiYu, Zhang MingGang, Wang YuanXin, Zhang KeJian. Risk factors of early rebleeding after endoscopic treatment of gastroesophageal varices[J]. Journal of Clinical Hepatology, 2013, 29(3): 178-183. |
[18] | Shao CuiPing, Xu XiaoYuan. Progress in the prevention and treatment of bleeding gastroesophageal varices in patients with cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(9): 647-650. |
[19] | Jin HongHui, Ding XiaoHong. ROC curve analysis of blood platelet and hyaluronic acid levels for diagnosing cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(6): 456-458. |
[20] | Cheng LiuFang, Li ZhangZheng. A multi-center survey of esophagogastic variceal bleeding in China[J]. Journal of Clinical Hepatology, 2012, 28(6): 462-464. |